Is the CDC blowing smoke? Recommended levels of anti-tobacco spending have little effect on cigarette use.
Marlow, Michael L.
In 2007, the Centers for Disease Control and Prevention (CDC)
released a report detailing "best practice" spending
recommendations for state tobacco control programs. According to the
report, "Research shows that the more states spend on comprehensive
tobacco control programs, the greater the reductions in smoking--and the
longer states invest in such programs, the greater and faster the
impact."
The CDC spending guidelines use research to form "best
practice" spending recommendations for each state. The report
claims:
Implementing a comprehensive
tobacco control program structure
at the CDC-recommended levels of
investment would have a substantial
impact. For example, if each
state sustained its recommended
level of funding for 5 years, an estimated
5 million fewer people in
this country would smoke. As a
result, hundreds of thousands of
premature tobacco-related deaths
would be prevented. Longer-term
investments would have even
greater effects.
This claim should be met with skepticism. At least four reasons
suggest that benefits from meeting spending targets are not as large as
the CDC argues:
* The CDC recommendations draw heavily on research from just two
states: California and Massachusetts. Those two states are considered
models of effective programs, in part, because they have the longest
funding histories. Even if highly effective, their success may not be
easily exported to other states.
* The CDC ignores studies that show little to no impact from
tobacco control programs.
* There is evidence, again ignored by the CDC, that little to no
connection exists between state spending on tobacco control and the
degree to which residents smoke.
* The CDC offers no empirical verification that implementing
recommended spending targets causes significant reductions in tobacco
use.
This article focuses on the last point above. Empirical
investigation of the connection between spending guidelines and tobacco
use is conducted to directly assess whether states that are closer to
CDC guidelines actually exhibit lower tobacco sales than states that do
not. Analysis focuses on two related issues. One is the fundamental
question of whether tobacco sales over 2000-2007 were influenced by
spending on tobacco control. The other is the policy question of whether
meeting CDC spending targets matters in efforts to reduce tobacco sales.
TOBACCO CONTROL LITERATURE
Studies of tobacco control programs often focus on California and
Massachusetts because of their long funding histories. Tobacco control
in California began in 1988 when voters approved the California Tobacco
Tax and Health Promotion Act of 1988 (Proposition 99), which increased
the state surtax on cigarettes by 25 cents per pack and earmarked
revenues for tobacco control programs. In 1992, a Massachusetts ballot
initiative raised taxes 25 cents per pack, with the resulting revenue to
be used for creation of the Massachusetts Tobacco Control Program.
Some empirical studies have indicated that the programs do indeed
reduce smoking. However, the studies' reliability is unclear. A
2003 Journal of Health Economics paper by Matthew Farrelly et al. points
out that most studies simply perform trend analysis on the introduction
of new tobacco control programs and ignore other factors that might
influence tobacco consumption. Those studies also focus heavily on
California or Massachusetts. Even if their conclusions are valid--that
tobacco control programs cause less smoking--it remains unclear whether
extrapolation to other states is appropriate.
[ILLUSTRATION OMITTED]
Early studies that control for one or more factors outside of
tobacco control programs uniformly show that the programs are highly
effective in lowering tobacco use. A 1995 American Economic Review paper
by T.-W. Hu et al. controlled for state excise taxes and tobacco firm
media expenditures and found that state spending lowered consumption in
California. A 1995 Journal of Public Health paper also by Hu et al.
estimated that a 25 cent state tax hike reduced taxed sales in
California when measured over about two years. Those two studies
controlled for effects of time on cigarette consumption, which may
control for various other factors--such as greater health concerns--that
affect smoking over time. However, the Hu team's studies focus on
California, the longest-lived state program, and examine effects on
taxed sales over very few and very early years of a program that began
in 1988.
The Farrelly paper examined tobacco control activities of all 50
states and concluded that state tobacco control expenditures lowered
taxed cigarette sales over 1981-2000, after controlling for excise
taxes, smuggling, time, and other state-specific factors. They also
estimated that aggregate cigarette sales would have fallen by an
additional 9 percent by 2000 if states had spent at minimum funding
levels advocated by the CDC. A 2005 American Journal of Public Health
paper by John Tauras et al. concluded that spending in the 50 states
lowered youth smoking prevalence and the number of cigarettes smoked
over 1991-2000, after controlling for other factors that might also
influence sales.
The studies discussed so far examined years in which many states
did not actively fund programs. The CDC only began publishing funding
data in 2000 because many states did not actively fund programs until
after the Master Settlement Agreement in 1998. It remains unclear
whether the experience of tobacco control programs prior to when most
states actively began funding the programs easily translates into
recommendations for many states that only began funding around 2000. It
is also unclear if experiences in the few states with relatively long
funding histories easily convey to the many states without such
histories.
BEST PRACTICES SPENDING TARGETS
The CDC's 2007 "best practices" report claims that a
range of $15 to $20 per capita is a reasonable annual target for each
state to fund tobacco control activities. Appropriate activities include
anti-smoking ads, cessation interventions (intensive counseling services
and cessation medications), and enforcement of age restrictions on the
purchase of tobacco.
Table 1 displays how state spending on tobacco control over
2000-2007 compared to CDC-recommended minimum levels. Percentages of
CDC-minimum levels are shown. Two states--Maine and
Mississippi--averaged over 100 percent over this period, and three
states--Michigan, Missouri, and Tennessee--spent nothing. Table 2
displays total spending in years 2000-2007 as well as average
percentages of CDC minimums in each of those years. Total spending (in
2005 dollars) has been declining since 2003, and percent of CDC minimums
has ranged between 33.6 percent and 46.9 percent. Aggregate spending is
$5.3 billion, which is roughly $18 per capita. The CDC is thus arguing
that states should have spent at least $8 billion more during those
years, for a total of $13.3 billion, to meet minimum recommended levels
of funding. That works out to roughly $44.30 per capita over those
years. The summary measures appear to indicate ample variation with
which to assess CDC claims that consistent meeting of recommended
spending targets over time leads to significant reduction in tobacco
use.
As mentioned previously, the CDC stresses the importance of
maintaining state funding over time at levels that meet or exceed
minimum targets. This suggests that it takes many years of tobacco
control activity before full effects of programs can be detected.
Spending is hypothesized to act as advertising: successful campaigns (in
this case) reduce demand both today and tomorrow. The Hu et al. American
Economic Review paper, the Farrelly et al. Journal of Health Economics
paper, and my 2006 Cato Journal paper each found some evidence that
cumulative measures of spending that discounted past spending on tobacco
control were associated with less tobacco use.
This article employs discount rates of 5, 10, 15, and 20 percent in
its analysis of the effectiveness of the CDC recommendations. This
article also considers a cumulative measure of funding adequacy as
defined by how closely states have met spending recommendations over
time. Table 3 displays cumulative measures of tobacco control spending
(in 2005 dollars) per capita. Values are shown for 2007, and so values
over 2000-2006 are included at discounted rates. Average values are
$19.53 and $11.68 for discount rates of 5 and 20 percent, respectively.
Table 4 displays cumulative measures of funding adequacy, as defined as
percentage of CDC minimum spending targets, at discount rates of 5 and
20 percent. Average values are 274 percent and 167 percent for discount
rates ors and 20 percent, respectively. Cumulative measures of funding
levels and adequacy thus range widely across states throughout the
period.
MODELING EFFECTS OF TOBACCO CONTROL
Taxed sales of cigarettes are estimated using a pooled and balanced
regression model over 2000-2007. A fixed effects model is estimated to
control for state-specific factors outside of the model. Total sample
size is 400 observations and represents all states across the eight-year
time period. The following relationship for taxed cigarette sales is
estimated:
[CIG.sub.it] = f([PRICE.sub.it], [PCY.sub.it], [UE.sub.it],
[BAN.sub.it], [SMUG.sub.it], [CONTROL.sub.it])
The subscript i refers to the 50 states and t refers to years 2000
to 2007. The dependent variable [CIG.sub.it] is the number of tax-paid
per-capita cigarette sales (in packs) and is obtained from William
Orzechowski and Robert Walker's 2008 monograph The Tax Burden of
Tobacco. The log of [CIG.sub.it] is examined, as is commonly done, and
allows direct estimation of the price elasticity of demand because the
log of the price variable is included on the right-hand side of the
equation. [PRICE.sub.it] is the price (in 2005 dollars) of a pack of
cigarettes, as reported by Orzechowski and Walker, and is hypothesized
to be inversely related to cigarette consumption.
Real per-capita personal income [PCY.sub.it] is obtained from U.S.
Department of Commerce data. The sign on [PCY.sub.it] is ambiguous
because, while cigarette demand may be income-elastic and therefore
exhibit a positive sign, higher income may also lower sales given common
perceptions that higher-income individuals smoke less. Unemployment
level [UE.sub.it] controls for the state of the economy and its sign is
ambiguous as well because it is unclear if high unemployment is
associated with more smoking from greater emotional distress or less
smoking from greater financial distress.
The smoking ban variable [BAN.sub.it] controls for the effect of
state-wide smoking bans in restaurants. Values of [BAN.sub.it] are set
to 0 prior to bans and 1 thereafter to capture effects on taxed sales.
Data on bans are obtained from a 2008 publication by the group Americans
for Nonsmokers Rights. Some researchers have found that smoking
restrictions lead to less smoking, which suggests that its sign will be
negative.
Tax-paid cigarette sales do not fully reflect in-state consumption
when smokers purchase some portion of cigarettes across state borders.
[SMUG.sub.it] is defined as the ratio of the own-state price to the
average for bordering states and is hypothesized to be inversely related
to taxed sales because higher values indicate higher incentives for
cross-border smuggling. Values for Hawaii and Alaska are set to 1
because they do not border other states and so their smokers are assumed
to not purchase from other states. Data are obtained from Orzechowski
and Walker (2008).
[CONTROL.sub.it] measures tobacco control spending and is measured
in two alternative ways. The first measure is spending (again, in 2005
dollars) per capita ([SPENDING.sub.it]) and the second is as a
percentage of CDC minimums ([ADEQUACY.sub.it]). As discussed above,
[SPENDING.sub.it] is commonly used in the literature and
[ADEQUACY.sub.it] measures CDC-defined funding adequacy. Data are
obtained from a 2008 publication by the group Campaign for Tobacco-Free
Kids. Cumulative measures of these variables are also examined to test
whether differences in funding levels exert lagged effects on tobacco
use over time and across states.
If states with relatively few smokers display less tolerance for
smoking and therefore spend more on tobacco control, my econometric
estimates of the effect of tobacco control spending will be inaccurate.
Instrumental variable estimation is one method of dealing with this
endogeneity problem and involves selection of a new variable that is
both highly correlated with the independent variable in question
(tobacco control spending) and also uncorrelated with all the other
causes of smoking. Real state per-capita tobacco settlement funds
[MSA.sub.it] are used as an instrument for [SPENDING.sub.it] and
[ADEQUACY.sub.it] because those funds should influence funding
availability, but it is unlikely that those funds independently
influence cigarette sales. (As a check for whether [MSA.sub.it] is a
weak instrument, we can determine whether the F-statistic exceeds 10
when testing the hypothesis that coefficients on all instruments are
zero. In this case, the F-statistic for [SPENDING.sub.it] was 18.1, and
for [ADEQUACY.sub.it] was 19.50, indicating that [MSA.sub.it] is a good
instrument.) Settlement revenues were based on a formula that included
smoking-attributable state Medicaid expenses and, while the agreement
did not dictate how funds were to be allocated, tobacco control
advocates argued that states should use those funds to significantly
expand tobacco control spending. Evidence, however, indicates that those
funds often go toward closing state government deficits and costs
associated with general health care programs. Tobacco settlement data
are obtained from Orzechowski and Walker's book.
CONTEMPORANEOUS SPENDING AND ADEQUACY
Table 5 displays estimates of tobacco control spending on cigarette
sales. Columns (1) and (2) display estimations with and without
instruments for tobacco control spending, and columns (3) and (4)
display estimations with and without instruments for adequacy. Price
coefficients, which measure price elasticities, lie between -0.82 and
-0.84 and are in line with the expectation that demand for cigarettes is
price inelastic. Per-capita income is found to exert negative and
significant influences on sales. Unemployment and smoking ban variables
do not exert significant effects. Smuggling is found to exert the
hypothesized negative effect on sales in all estimations except in
column (1). Coefficients on both measures of tobacco control spending
are all positive and significant. Positive coefficients run counter to
CDC arguments that sales fall with higher spending. The implication is
that higher contemporaneous spending raises cigarette sales, and this
result is found for estimations with and without instrumental variables.
At least two possibilities might explain positive coefficients on
spending and adequacy measures:
* A "James Dean" effect might exist whereby spending on
tobacco control raises social taboos against smoking and then
(perversely) causes more smoking. There is some evidence that this
happens with younger smokers following the introduction of smoking bans.
* More likely, specification error may exist when effects of
spending on sales are longer-lived than the contemporaneous relation in
Table 5. Tables 6 and 7 show that cumulative effects of spending and
adequacy on sales are estimated to be either negative or zero, and so
positive coefficients in Table 5 are likely the result of specification
error.
It is also apparent that t-values associated with spending and
adequacy coefficients are lower in instrumental value estimations. This
commonly occurs because standard errors are biased downward in ordinary
least squares estimations when endogeneity is present. This suggests
that endogeneity is a problem and so only instrumental variable
estimation of cumulative effects from spending and adequacy are
displayed in the following tables.
SPENDING AND ADEQUACY
Table 6 displays estimations of cumulative control spending on
cigarette sales with four alternative discount rates. Prices and income
exert significant and negative effects in all four estimations, and
effects of unemployment and smoking bans (except in column 4 where it is
weakly significant and negative) cannot be distinguished statistically
from zero. Smuggling exerts weakly significant and negative effects in
all estimations. Cumulative spending measures exert no significant
effects on sales in all estimations. Again, evidence does not support
CDC claims that states that spend more will also have less tobacco use.
Table 7 displays estimations based on measures of cumulative
spending adequacy. Effects from price, income, and unemployment mirror
those of the previous table. Although smoking bans exerted negative and
weakly significant effects in one instance in the previous table, it
never exerts a significant effect in Table 7. Smuggling exerts
significant and negative effects only when adequacy measures are
discounted at 15 and 20 percent; it exerted negative effects in all
estimations of the previous table. Spending adequacy exerts negative and
significant effects when discounted at S and 10 percent. No effects are
found when adequacy measures are discounted at 15 and 20 percent.
Therefore, there is some support for CDC claims concerning funding
adequacy when this measure is discounted at rates of 5 and 10 percent,
but not at rates of 15 and 20 percent.
It is also worth noting that the effects of funding adequacy
discounted at a 5 percent rate are statistically significant at the 95
percent confidence level, and at the 90 percent confidence level when
funding adequacy is discounted at a 10 percent rate. In this log-linear
specification, estimated coefficients of -0.0001 on funding adequacy at
discount rates of 5 and 10 percent can be interpreted as unit changes in
the cumulative value of adequacy associated with a 100 * -0.0001 percent
change in taxed cigarette sales. Taxed sales fall by 0.011 percent for
each additional unit. Based on average taxed sales in 2007 of 68 packs
per capita, an additional unit rise in ADEQUACY would lower annual sales
by 0.68 packs per capita. This estimate suggests economic effects are
trivial.
CONCLUSIONS
Empirical evidence does not generally support the CDC claim that
states that spend more on tobacco control deter more tobacco use than
states that spend less. Contemporaneous spending on tobacco control is
never found to exert an inverse effect on sales, and at times is found
to exert a significant and positive effect on sales, contrary to the
claims of the CDC. The true effect, however, appears to be zero based on
current and past spending discounted at various rates. There is limited
support for CDC claims regarding its recommendations on funding adequacy
when this spending measure is discounted at rates of 5 and 10 percent,
but not at rates of 15 and 20 percent. When significant, however, these
effects arise at fairly low levels of confidence and with trivial
effects on cigarette sales, and therefore suggest very cautious support
for the CDC recommendations concerning adequacy. These conclusions are
based on a battery of tests that consider various measures of
contemporaneous and past spending and adequacy and are conducted over an
eight-year period in which over $5 billion (in 2005 dollars), or roughly
$18 per capita, was spent on tobacco control.
This study raises questions about the process by which the CDC
determines its spending recommendations and whether the process is
designed to reach a particular conclusion about tobacco control policy
rather than to uncover policies that may best allocate resources toward
controlling tobacco use. There may be a similarity to what I noted in a
2008 Econ Journal Watch paper on why the CDC and various researchers
conclude that indoor smoking bans exert either positive or no adverse
economic effects on restaurants and bars when, in fact, published
studies demonstrate that numbers of businesses harmed are not zero.
Factors include biases by governments and researchers that favor
government solutions to perceived smoking problems, ample funding for
researchers that conclude that bans exert no economic harm, simply
ignoring industry-funded research that indicates some degree of harm,
and tacit agreement between many researchers to not openly scrutinize
the quality of colleagues' published research on this topic. It
would be interesting to explore whether any of those factors might be
influencing the policy process whereby the CDC makes spending
recommendations regarding tobacco control. Those factors might also
explain why the CDC is not compelled to demonstrate the effectiveness of
its recommendations.
Readings
* "Adult Smoking Intervention Programmes in Massachusetts: A
Comprehensive Approach with Promising Results," by H. Robbins, M.
Krakow, and D. Warner. Tobacco Control, Vol. 11, Sup. 2 (2002).
* "Decreased Youth Tobacco Use in Massachusetts 1996-1999:
Evidence of Tobacco Control Effectiveness," by S. Soldz, T. W.
Clark, E. Stewart, C. Celebucki, and D. Walker. Tobacco Control, Vol.
11, Sup. 2 (2002).
* "Determinants of State Tobacco-Control Expenditures,"
by Michael L. Marlow. Applied Economics, Vol. 40, No. 7 (2008).
* "Do Expenditures on Tobacco Control Decrease Smoking
Prevalence?" by Michael L. Marlow. Applied Economics, Vol. 41
(2009).
* "Do Tobacco-Control Programs Lower Tobacco Consumption?
Evidence from California," by Michael L. Marlow. Public Finance
Review, Vol. 35 (November 2007).
* "Has the California Tobacco Control Program Reduced
Smoking?" by J. P. Pierce, E. A. Gilpin, S. L. Emery, M. M. White,
M. Rosbrook, and C. Berry. Journal of the American Medical Association,
Vol. 280 (1998).
* "Honestly, Who Else Would Fund Such Research? Reflections of
a Non-Smoking Scholar," by Michael L. Marlow. Econ Journal Watch,
Vol. 5, No. 2 (2008).
* "Impact of the American Stop Smoking Intervention Study on
Cigarette Consumption," by M. W. Manley, J. P. Pierce, E. A.
Gilpin, B. Rosbrook, C. Berry, and L. Wun. Tobacco Control, Vol. 6, Sup.
2 (1997).
* "Impact of the Massachusetts Tobacco Control Programme:
Population Based Trend Analysis," by Lois Biener, Jeffrey E.
Harris, and William Hamilton. BMJ, Vol. 321 (August 5, 2000).
* "Reducing Cigarette Consumption in California: Tobacco Taxes
vs. an Anti-Smoking Media Campaign," by T.-W. Hu, H.-Y. Sung, and
T. E. Keeler. American Journal of Public Health, Vol. 85 (1995).
* "State Expenditures for Tobacco-Control Programs and the
Tobacco Settlement," by Cary P. Gross et al. New England Journal of
Medicine, Vol. 347 (October 3, 2002).
* "State Tobacco Control Spending and Youth Smoking," by
John A. Tauras et al. American Journal of Public Health, Vol. 95
(February 2005).
* "The Effects of Smoking Ban Regulations on Individual
Smoking Rates," by Hielke Buddelmeyer and Roger Wilkins. University
of Melbourne discussion paper 1737, 2005.
* "The First Decade of the Massachusetts Tobacco Control
Program," by Howard K. Ko et al. Public Health Reports, Vol. 120
(Sept.-Oct. 2005).
* "The Impact of Clean Indoor Air Laws and Cigarette Smuggling
on Demand for Cigarettes: An Empirical Model," by A. A. Yurekli and
P. Zhang. Health Economics, Vol. 2 (March 2000).
* "The Impact of Tobacco Control Program Expenditures on
Aggregate Cigarette Sales: 1981-2000," by Matthew C. Farrelly,
Terry F. Pechacek, and Frank J. Chaloupka. Journal of Health Economics,
Vol. 22 (2003).
* "The State Antismoking Campaign and the Industry Response:
The Effects of Advertising on Cigarette Consumption in California,"
by T.-W. Hu, H.-Y. Sung, and T. E. Keeler. American Economic Review,
Vol. 85 (May 1995).
* The Tax Burden on Tobacco: Historical Compilation 2007, by
William Orzechowski and Robert C. Walker. 2008.
* "Tobacco Control Programs and Tobacco Consumption," by
Michael L. Marlow. Cato Journal, Vol. 26 (Fall 2006).
* "Trends in Prevalence of Current Smoking: Massachusetts and
States without Tobacco Control Programmes, 1990-1999," by J. M.
Weintraub and W. L. Hamilton. Tobacco Control, Vol. 11, Sup. 2 (2002).
BY MICHAEL L. MARLOW
California Polytechnic State University
Michael k. Marlow is professor of economics in the Orfalea College
of Business at California Polytechnic State University.
Table 1
Keeping Up With the CDC?
Annual state spending on tobacco
control for 2000-2007 as percentages
of CDC minimums
Average Minimum Maximum
(percent) (percent) (percent)
Alabama 7 1 22
Alaska 48 17 77
Arizona 96 66 132
Arkansas 82 0 103
California 57 45 82
Colorado 54 16 110
Connecticut 5 0 19
Delaware 56 0 119
Florida 26 1 56
Georgia 30 5 49
Hawaii 77 39 95
Idaho 11 5 17
Illinois 30 13 71
Indiana 64 31 101
Iowa 36 26 49
Kansas 4 3 6
Kentucky 15 9 23
Louisiana 25 2 42
Maine 139 123 168
Maryland 67 30 99
Massachusetts 56 7 136
Michigan 0 0 0
Minnesota 94 65 122
Mississippi 108 0 165
Missouri 0 0 0
Montana 35 4 74
Nebraska 35 3 53
Nevada 30 22 33
New Hampshire 14 0 28
New Jersey 42 23 67
New Mexico 35 16 56
New York 45 31 89
North Carolina 19 0 40
North Dakota 27 0 38
Ohio 73 35 97
Oklahoma 25 8 46
Oregon 31 14 53
Pennsylvania 49 0 80
Rhode Island 25 10 33
South Carolina 5 0 8
South Dakota 15 8 31
Tennessee 0 0 0
Texas 9 5 12
Utah 44 39 47
Vermont 68 57 82
Virginia 40 32 57
Washington 68 45 82
West Virginia 41 38 42
Wisconsin 45 32 68
Wyoming 41 12 80
SOURCE: Campaign for Tobacco-Free Kids, "History of State
Spending for Tobacco Prevention," 2008
Table 2
National Totals
Annual state tobacco control
Total Percent
Spending of CDC
($2,005) Minimum
2000 $771.3M 42.5
2001 813.1M 46.1
2002 814.0M 46.9
2003 715.9M 42.1
2004 561.3M 33.9
2005 538.2M 33.6
2006 533.9M 34.4
2007 562.6M 37.2
SOURCE: Campaign for Tobacco-Free Kids,
"History of State Spending for Tobacco
Prevention," 2008
Table 3
Per-Capita Spending
Discounted cumulative per-capita
tobacco control spending, in 2005 dollars
5% 20%
Alabama $ 2.69 $ 1.08
Alaska $ 41.36 $ 28.41
Arizona $ 32.57 $ 18.37
Arkansas $ 37.66 $ 24.02
California $ 18.43 $ 10.57
Colorado $ 20.20 $ 13.58
Connecticut $ 2.14 $ 1.13
Delaware $ 42.04 $ 33.18
Florida $ 8.21 $ 3.43
Georgia $ 9.89 $ 4.85
Hawaii $ 46.11 $ 27.41
Idaho $ 6.12 $ 3.51
Illinois $ 10.60 $ 5.27
Indiana $ 24.47 $ 12.16
Iowa $ 16.23 $ 9.13
Kansas $ 1.70 $ 1.14
Kentucky $ 6.27 $ 3.28
Louisiana $ 11.00 $ 7.40
Maine $ 82.67 $ 48.32
Maryland $ 25.40 $ 13.58
Massachusetts $ 20.44 $ 8.86
Michigan $ 0.00 $ 0.00
Minnesota $ 36.44 $ 20.29
Mississippi $ 48.04 $ 24.66
Missouri $ 0.00 $ 0.00
Montana $ 25.27 $ 17.94
Nebraska $ 18.30 $ 9.45
Nevada $ 12.26 $ 7.27
New Hampshire $ 785.00 $ 3.12
New Jersey $ 15.22 $ 8.00
New Mexico $ 17.85 $ 11.96
New York $ 15.91 $ 10.76
North Carolina $ 6.68 $ 5.20
North Dakota $ 24.38 $ 17.10
Ohio $ 27.27 $ 16.38
Oklahoma $ 10.71 $ 7.24
Oregon $ 12.69 $ 6.46
Pennsylvania $ 18.37 $ 12.04
Rhode Island $ 15.77 $ 8.80
South Carolina $ 1.89 $ 1.01
South Dakota $ 11.68 $ 6.15
Tennessee $ 0.00 $ 0.00
Texas $ 2.73 $ 1.50
Utah $ 19.32 $ 11.74
Vermont $ 60.19 $ 35.05
Virginia $ 14.52 $ 8.49
Washington $ 25.74 $ 16.51
West Virginia $ 22.50 $ 13.49
Wisconsin $ 17.72 $ 9.51
Wyoming $ 42.99 $ 31.79
SOURCES: Campaign for Tobacco-Free Kids,
"History of State Spending for Tobacco Prevention,"
2008; author's calculations
Table 4
CDC Recommendations
and Total Spending
Discounted cumulative measures of
funding adequacy as a percentage of
CDC minimum targets
Percent of CDC
recommendation
5% 20%
discount discount
rate rate
Alabama 41 17
Alaska 335 236
Arizona 637 378
Arkansas 566 369
California 379 224
Colorado 376 263
Connecticut 33 18
Delaware 418 333
Florida 159 68
Georgia 190 96
Hawaii 514 315
Idaho 74 44
Illinois 193 98
Indiana 408 208
Iowa 236 137
Kansas 25 17
Kentucky 98 53
Louisiana 176 120
Maine 924 555
Maryland 435 240
Massachusetts 342 151
Michigan 0 0
Minnesota 615 353
Mississippi 694 364
Missouri 0 0
Montana 251 183
Nebraska 225 120
Nevada 202 126
New Hampshire 83 33
New Jersey 274 148
New Mexico 244 168
New York 314 217
North Carolina 139 110
North Dakota 189 134
Ohio 487 300
Oklahoma 171 119
Oregon 200 105
Pennsylvania 340 226
Rhode Island 162 92
South Carolina 31 18
South Dakota 98 53
Tennessee 0 0
Texas 56 32
Utah 300 190
Vermont 451 269
Virginia 267 160
Washington 469 310
West Virginia 276 169
Wisconsin 295 163
Wyoming 297 224
Table 5
CDC Recommendations and Cigarette Sales
Effects of spending and funding adequacy on the log of cigarette
sales, with and without instrumental variables
(2)
Instrument for
(1) Spending
Real price per pack (PRICE) -0.8430 *** 0.8430 ***
(10.35) (10.35)
Per-capita income (PCY) -3.2E-05 *** -2.9E-05 ***
(764) (6.37)
Unemployment (UE) 0.0037 0.0011
(0.48) (0.14)
State-wide smoking -0.0198 -0.0249
ban in restaurants (BAN) (1.12) (1.38)
Ratio of in-state price to -0.1863 -0.2148 *
border states' prices (SMUG) (1.51) (1.70)
Real per-capita spending on 0.011495 *** 0.02778 **
tobacco control (SPENDING) (4.72) (2.17)
Tobacco control spending
as percentage of CDC
minimums (ADEQUACY)
Constant 10.39062 *** 10.14091 ***
(26.71) (24.82)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0805 0.0825
F-statistic 146.07 138.75
Observations 400 400
(4)
Instrument for
(3) Adequacy
Real price per pack (PRICE) -0.8205 *** -0.8205 ***
(9.84) (9.84)
Per-capita income (PCY) -3.22E-05 *** -2.93E-05 ***
(7.56) (6.37)
Unemployment (UE) 0.0029 -0.0011
(0.39) (0.14)
State-wide smoking -0.0238 -0.0249
ban in restaurants (BAN) (1.34) (1.38)
Ratio of in-state price to -0.2286 * -0.2148 *
border states' prices (SMUG) (1.84) (1.70)
Real per-capita spending on
tobacco control (SPENDING)
Tobacco control spending 0.0008 *** 0.0022 **
as percentage of CDC 3.98 2.17
minimums (ADEQUACY)
Constant 10.3865 *** 10.1327 ***
(26.78) (24.74)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0812 0.0825
F-statistic 143.40 138.75
Observations 400 400
NOTES: *** significant 1% level (two-tailed test); ** significant
at 5 level; * significant as 10 percent level; t-statistics in
parentheses
Table 6
Cumulative Tobacco Control Spending and Cigarette Sales
Effects of cumulative control spending on cigarette sales with
instrumental variable for spending
(1) (2)
Real price per pack (PRICE) -0.8241 *** -0.8286 ***
(9.76) (9.79)
Per-capita income (PCY) -3.41E-05 *** -3.48E-05 ***
(6.45) (6.67)
Unemployment (UE) -0.0017 -0.0024
(0.21) (0.29)
State-wide smoking -0.0289 -0.0296
ban in restaurants (BAN) (1.57) (1.61)
Ratio of in-state price to -0.2244* -0.2269*
border states' prices (SMUG) (1.76) (1.78)
Discount Rate
5% 10%
Real per-capita spending on 0.0004 0.0008
tobacco control (SPENDING) (0.50) (0.79)
Constant 10.4208 *** 10.4727 ***
(23.99) (24.00)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0830 0.0830
F-statistic 136.90 13705
Observations 400 400
(3) (4)
Real price per pack (PRICE) -0.8347 *** -0.8420 ***
(9.83) (9.89)
Per-capita income (PCY) -3.56E-05 *** -3.62E-05 ***
(6.93) (7.19)
Unemployment (UE) -0.0032 -0.0040
(0.40) (0.50)
State-wide smoking -0.0302 -0.0306*
ban in restaurants (BAN) (1.65) (1.68)
Ratio of in-state price to -0.2268* -0.2248*
border states' prices (SMUG) (1.78) (1.77)
Discount Rate
15% 20%
Real per-capita spending on 0.0014 0.0022
tobacco control (SPENDING) (1.11) (1.44)
Constant 10.5321 *** 10.5940 ***
(24.06) (24.17)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0829 0.0815
F-statistic 137.30 13765
Observations 400 400
NOTES: *** significant 1% level (two-tailed test); ** significant
at 5 level; * significant as 10 percent level; t-statistics in
parentheses
Table 7
Cumulative Spending, CDC Recommendations, and Cigarette Sales
EFfects of cumulative adequacy on cigarette sales with instrumental
variable for adequacy of spending
(1) (2)
Real price per pack (PRICE) -0.7956 *** -0.7939 ***
(9.47) (9.40)
Per-capita income (PCY) -2.61E-05 *** -2.72E-05 ***
(5.03) (5.28)
Unemployment (UE) -0.0044 -0.0040
(0.55) (0.50)
State-wide smoking 0.0199 ~
-0.0213
ban in restaurants (BAN) (1.09) (1.16)
Ratio of in-state price to -0.1933 -0.2027
border states' prices (SMUG) (1.52) (1.60)
Discount Rate
5% 10%
Tobacco control spending -0.0001 ** -0.0001 *
as percentage of CDC (2.22) (1.94)
minimums (ADEQUACY)
Constant 9.9678 *** 9.9985 ***
(23.08) (22.98)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0824 0.0826
F-statistic 138.84 138.37
Observations 400 400
(3) (4)
Real price per pack (PRICE) -0.7941 *** -0.7965 ***
(9.34) (9.31)
Per-capita income (PCY) -2.82E-05 *** -2.93E-05 ***
(5.56) (5.86)
Unemployment (UE) -0.0034 -0.0027
(0.43) (0.34)
State-wide smoking -0.0227 -0.0240
ban in restaurants (BAN) (1.24) (1.31)
Ratio of in-state price to -0.2106 * -0.2163 *
border states' prices (SMUG) (1.66) (1.71)
Discount Rate
15% 20%
Tobacco control spending -0.0001 0.0001
as percentage of CDC (1.64) (1.30)
minimums (ADEQUACY)
Constant 10.0418 *** 10.0962 ***
(22.91) (22.91)
R-squared 0.95 0.95
Mean dependent variable 4.26 4.26
S.E. of regression 0.0827 0.0829
F-statistic 137.91 137.50
Observations 400 400
NOTES: *** significant 1% level (two-tailed test); ** significant
at 5 level; * significant as 10 percent level; t-statistics in
parentheses